MetaVida: Why Treatment-Resistant Depression Requires A New Approach
For many individuals living with depression, traditional treatment—therapy combined with antidepressant medication—can be effective. But for a significant portion of people, these approaches fall short.
This condition, known as treatment-resistant depression (TRD), typically refers to individuals who have not responded to two or more antidepressant trials. For these clients, the experience is often marked by frustration, discouragement, and a deep sense of being stuck despite actively engaging in care.
As the behavioral health field evolves, one reality has become increasingly clear: treatment-resistant depression requires new, more advanced approaches that address both the mind—thoughts, emotions, consciousness—and the brain, including cognitive abilities, sensory processing, motor control, and regulation of bodily functions.
The Growing Need for Innovation
Rates of depression continue to rise across the United States, and with them, the number of individuals who do not respond to traditional treatment alone. These clients often cycle through medications, engage in therapy, and still experience persistent symptoms such as low mood, emotional numbness, fatigue, and impaired functioning.
At MetaVida, a program of Futures Recovery Healthcare, this unmet need has driven the development of a new model of care—one of holistic wellness that integrates neuroscience, psychiatry, psychotherapy, and alternative medicine into a comprehensive outpatient experience.
“We are seeing more individuals than ever who are doing everything right—engaging in therapy, trying medications—and still not getting the relief they need. MetaVida was created as a direct response to this growing population. We knew we had to offer something more—something that addresses the brain in new ways while still supporting the whole person.”
— Dr. Tammy Malloy, CEO, Futures Recovery Healthcare
Moving Beyond Traditional Treatment
Traditional approaches to depression often focus on neurotransmitters such as serotonin and dopamine. While these treatments can be effective, they may not fully address underlying disruptions in brain circuitry that contribute to persistent depression.
“We new we had to offer something more–something that addresses the brain in new ways while still supporting the whole person.”
— Dr. Tammy Malloy, CEO, Futures Recovery Healthcare
MetaVida introduces advanced, evidence-based interventions that directly target these neurological pathways, including:
Transcranial Magnetic Stimulation (TMS)
TMS is a non-invasive treatment that uses magnetic pulses to stimulate areas of the brain associated with mood regulation. Clinical research has shown response rates of approximately 50–60% in individuals with treatment-resistant depression, with many achieving meaningful symptom improvement.
At MetaVida, TMS protocols are structured over 6–12 weeks, allowing for both acute symptom reduction and continued stabilization.
Ketamine & Spravato® Therapy
Ketamine-based treatments, including IV Ketamine and Spravato® (esketamine), represent a significant advancement in treating TRD. These therapies work on glutamate pathways and support neuroplasticity, helping the brain form new connections.
Unlike traditional antidepressants, ketamine treatments can provide rapid symptom relief, often within hours or days, making them especially valuable for individuals experiencing severe depression or suicidal ideation.
At MetaVida, ketamine is delivered within a structured protocol that includes both induction and maintenance phases, paired with therapeutic support to enhance long-term outcomes.
The Power of an Outpatient Model
One of the most important aspects of MetaVida is its outpatient structure.
Clients are able to:
- Live at home or in supportive housing
- Maintain work, school, and family responsibilities
- Receive advanced, structured treatment during the day
- Apply progress in real time within their daily lives
This model fills a critical gap in care—serving as a bridge between traditional outpatient therapy and more intensive levels of care. It is particularly effective for individuals who need more than weekly therapy but do not require residential treatment.
A New Path Forward
Treatment-resistant depression is not a failure of the individual—it is a signal that a different clinical approach is needed. MetaVida represents a shift toward a more integrated, personalized model of care—one that combines evidence-based neuroscience with compassionate, whole-person treatment.
For individuals who have tried everything and still feel stuck, this approach offers something many have been searching for:
A new path forward—and renewed hope for healing.
To Make A Referral
Ad********@***********************re.com
866-716-8762
About MetaVida Wellness Center
MetaVida, a program of Futures Recovery Healthcare, is an advanced outpatient mental health program designed for individuals who have not achieved optimal outcomes through traditional therapy or medication alone. MetaVida integrates psychiatry, psychotherapy, and neuroscience-based treatments—including Transcranial Magnetic Stimulation (TMS) and ketamine-based therapies.
About Futures Recovery Healthcare
Futures Recovery Healthcare is a leading provider of integrated mental health and substance use disorder treatment, offering a full continuum of care including Detox, Residential, Partial Hospitalization (PHP), and Intensive Outpatient (IOP) programs in a private, clinically sophisticated setting in Tequesta, Florida.
